# John Moolenaar

Type: Person

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/john-moolenaar
Canonical HTML page: https://getlegalbrief.com/entity/john-moolenaar

## Recent coverage (2 stories)

### Harvard's 2-Committee Probe Tests Foreign-Funding Disclosure Law
2026-08-15 22:02:54 · Sentiment: Negative · Impact: 6/10 · Sources: 2

The congressional investigation into Harvard's alleged use of Harvard Global to circumvent foreign-funding disclosure requirements carries significant regulatory and legal implications. Compliance teams, higher-ed counsel, and RegTech vendors should parse the committees' allegations for emerging enforcement priorities under Section 117.
Full story: https://getlegalbrief.com/story/harvard-ccp-probe-legal-regtech

### US Lawmakers Warn of Strategic Risk in Chinese Pharmaceutical Dependency
2026-03-19 00:20:24 · Sentiment: Negative · Impact: 8/10 · Sources: 3

The House Select Committee on China has raised alarms over the United States' increasing reliance on Chinese-made active pharmaceutical ingredients and biotech innovation. Lawmakers argue that Beijing is applying a proven industrial playbook to dominate the global medicine supply chain, posing significant national security and regulatory challenges.
Full story: https://getlegalbrief.com/story/us-china-pharmaceutical-supply-chain-risk

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.